Latest Breaking News On - Immunos therapeutics - Page 4 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel . AKAMPIONApril 12, 2021 GMT - Company forms international consortium with ProteoGenix SAS and Amsterdam UMC Schlieren (Zurich Area), Switzerland – April 12, 2021 – ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cancer and autoimmune diseases, announced today that is has received public funding from the European Union’s Eurostars-2 Programme and the Swiss Innovation Agency Innosuisse. The funds have been granted for the development of a pioneering HLA-open conformer-specific antibody to treat chronic inflammatory rheumatic diseases. Research will be conducted by a consortium with ProteoGenix SAS (Strasbourg, France) and Amsterdam University Medical Centres (Amsterdam, The Netherlands).

Switzerland generalNoord hollandMarroquin belaunzaranLudger wess ines regina buthPhilippe funfrockSeanr smithSchroder adveqVu university medical center vumcAcademic medical centerSwiss innovation agency innosuisseCompany contactCardiovascular sciencesBioinvest ltdLife sciences fundEuropean union eurostarsAmsterdam university medical centres